Revvity, Inc.

Waltham, Massachusetts

Classification

Public

About

About

Revvity is a global company that excels in providing innovative solutions and technologies to enable better health and safety outcomes across various industries. The company's mission is to improve human and environmental health through its cutting-edge products and services, which span a wide range of applications, including life sciences, diagnostics, environmental monitoring, food safety, and industrial testing. Product Breakdown: Revvity offers an extensive portfolio of products and solutions designed to address critical challenges and drive advancements in various domains. Life Sciences and Diagnostics: Genomics: Revvity provides advanced genomic analysis tools, including DNA sequencers, microarray platforms, and associated software, empowering researchers to study genetic variations and gain insights into diseases and human health. Drug Discovery and Development: The company offers a broad range of solutions for drug discovery, such as high-throughput screening systems, imaging technologies, and informatics software to accelerate the development of novel pharmaceuticals. In Vitro Diagnostics (IVD): Revvity's IVD solutions include diagnostic kits, reagents, and instrumentation for clinical laboratories, aiding in the detection and monitoring of various diseases, including cancer, infectious diseases, and genetic disorders. Environmental Health: Environmental Monitoring: Revvity delivers advanced instruments and software for monitoring and analyzing environmental pollutants, ensuring compliance with regulatory standards and supporting environmental research. Industrial Hygiene and Safety: The company offers solutions for workplace safety and industrial hygiene, including gas analyzers, radiation detectors, and personal protective equipment (PPE), safeguarding workers from occupational hazards. Food and Beverage Safety: Food Testing Solutions: Revvity's food testing instruments and services enable the detection of contaminants, allergens, and adulterants in food products, ensuring food safety and quality. Beverage Testing Solutions: The company provides analytical instruments to assess the quality and authenticity of beverages, including alcoholic beverages, juices, and water. Informatics and Software: Revvity offers a range of informatics and software solutions to support data management, analysis, and collaboration for scientific research and laboratory operations. Laboratory Services: In addition to its product offerings, Revvity offers laboratory services, including analytical testing, genomics services, and consulting, assisting customers in achieving their scientific and business objectives. Revvity's products are widely used across academic and research institutions, healthcare facilities, pharmaceutical and biotechnology companies, industrial laboratories, and government organizations. The company's commitment to innovation, quality, and customer satisfaction has earned it a reputation as a leading provider of solutions that positively impact human health and the environment.

Financials

Revenue & Profit

Revenue

Valuation

Valuation

Ratios

Revenue / EBITDA
$123 MM
Valuation / Revenue
$123 MM
Valuation / Employees
$123 MM
EBITDA / Revenue
$123 MM
1-Year CAGR (Revenue)
03
3-Year CAGR (Revenue)
11
1-Year CAGR (Employees)
19
3-Year CAGR (Employees)
96

People

Employee Figures

Employees

Key Executives

NameTitleSocialsEmailPhone
John DoeEmployee
--
Jane DoeEmployee
John DoeEmployee
John DoeEmployee

401K

Total Active Participants
1234
No. Participants with Account Balances
56789
Total Liabilities Start of Year
1234
Total Assets Start of Year
56789

Deals

M&A2024-03-15Completed

Seller

Founders Group

Investor Sponsors

NorthBridge PE

Deal Amount

$120M

Target Company Valuation

$1.20 MM

Techniques

Acquisition of Assets, Taken Private

Stake Tags

100%

Is PE deal

Yes

Is deal PE backed

Yes

Total Acquired

100%

Secondary Transaction2023-09-01Canceled

Target

BrightHealth Technologies

Seller

Early Investors Consortium

Investor Sponsors

--

Deal Amount

Undisclosed

Target Company Valuation

NaN

Techniques

Secondary Sale, Management Buy-out (MBO)

Stake Tags

Majority

Is PE deal

No

Is deal PE backed

Yes

Total Acquired

65%

Funding

Keywords

Keywords

Classified

Private